Overview
NTHI market data
Price History
NTHI price chart · 1M
- O
- 2.78
- H
- 2.78
- L
- 2.72
- C
- 2.72
- Vol
- 720.00
Daily history from Mar 26, 2025
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.78
- Previous Close
- $2.77
- Day High
- $2.78
- Day Low
- $2.72
- 52 Week High
- $11.88
- 52 Week Low
- $2.52
- 7 Day Return
- -0.73%
- 30 Day Return
- -8.26%
- 90 Day Return
- -18.32%
- 1 Year Return
- -74.32%
- Daily Notional Volume
- $2K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.20 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -48,876.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.50 – $12.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $79.2M · P/S 990.19.
Company News
10 captured
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu DhabiGlobenewswire Inc ·
NeOnc Technologies Appoints Ali Alabedin to Its Board of DirectorsGlobenewswire Inc ·
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next FrontierGlobenewswire Inc ·
NeOnc Charting New Nasal Route to Treating Brain CancerGlobenewswire Inc ·